|
|
|
Corporate Profile: Intermune
Pharmaceuticals
| Summary: |
InterMune
Pharmaceuticals, Inc., develops and commercializes
innovative products for the treatment of serious
pulmonary and infectious diseases and congenital
disorders. |
| Address (HQ):
|
3280 Bayshore Blvd
Brisbane, CA 94005 |
| Phone #'s (HQ): |
Main |
(415) 466-2200 |
| Human Resources |
(415) 466-2200 |
| Investor Relations |
not known |
| Fax #'s (HQ): |
Main |
(415) 466-2300 |
| Human Resources |
(415) 466-2613 |
| Investor Relations |
not known |
| Financial
information: |
| Intermune was purchased by Roche in 2014. |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
